Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26315807 | 0.94 | HSD17B10 (0.55) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL26315776 | 0.89 | EPHX2 (0.57) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL3494897 | 0.87 | PHF8 (0.46) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL10021727 | 0.85 | FAAH (0.50) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL25490376 | 0.83 | CNR2 (0.44) | CYP1A2CYP2D6MAPTTSHRCNR2 | |
| SCHEMBL22508744 | 0.82 | HSD17B10 (0.47) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL22508727 | 0.82 | TSHR (0.51) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| SCHEMBL21291251 | 0.82 | NOD1 (0.40) | — | |
| SCHEMBL12362917 | 0.81 | CNR2 (0.52) | CNR2L3MBTL1 | |
| SCHEMBL26616605 | 0.81 | CYP1A2 (0.49) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025093800-A1 | COMPOUNDS AND ANTIBODIES FOR THE IMMUNODETECTION OF CITRININ | UNIVERSITAT DE VALÈNCIA (ES) | 2025-05-08 | — | — | WO | disclosed |
| US-20230293701-A1 | LIGAND COMPOUNDS, CONJUGATES, AND APPLICATIONS THEREOF | ARGORNA PHARMACEUTICALS CO., LTD. (CN) | 2023-09-21 | — | — | US | disclosed |
| WO-2023121753-A1 | BIOMOLECULE-POLYMER-PHARMACEUTICAL AGENT CONJUGATES FOR DELIVERING THE PHARMACEUTICAL AGENT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-06-29 | — | — | WO | disclosed |
| US-9242010-B2 | Living copolymer-protein/peptide hybrids for biomedical applications | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2016-01-26 | — | — | US | disclosed |
| US-9242010-B2 | Living copolymer-protein/peptide hybrids for biomedical applications | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2016-01-26 | — | — | US | disclosed |
| US-9242010-B2 | Living copolymer-protein/peptide hybrids for biomedical applications | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2016-01-26 | — | — | US | disclosed |
| US-20110262991-A1 | Living Copolymer-Protein/Peptide Hybrids for Biomedical Applications | THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2011-10-27 | — | — | US | disclosed |
| US-20110262991-A1 | Living Copolymer-Protein/Peptide Hybrids for Biomedical Applications | THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2011-10-27 | — | — | US | disclosed |
| US-20110262991-A1 | Living Copolymer-Protein/Peptide Hybrids for Biomedical Applications | THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2011-10-27 | — | — | US | disclosed |
| WO-2009140683-A1 | LIVING COPOLYMER PROTEIN/PEPTIDE HYBRIDS FOR BIOMEDICAL APPLICATIONS | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140683-A1 | LIVING COPOLYMER PROTEIN/PEPTIDE HYBRIDS FOR BIOMEDICAL APPLICATIONS | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2009-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293701-A1 | LIGAND COMPOUNDS, CONJUGATES, AND APPLICATIONS THEREOF | ASGR1, HAVCR2, SLC10A1 | CYP1A2 2665/4885CYP2D6 1274/4885MAPT 2769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.